Childhood epilepsy and autism spectrum disorders: Psychiatric problems, phenotypic expression, and anticonvulsants

Neuropsychology Review

Volumn 22, Issue 3, 2012, Pages 271-279

  Robinson, Sally J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

ADHD; Antiepileptic; Anxiety; Asperger syndrome; Cognitive functioning; Depression; Pervasive developmental disorder

Indexed keywords

ANTICONVULSIVE AGENT;

ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR DISORDER; CHILD; COMORBIDITY; DEPRESSION; EPILEPSY; HUMAN; PHENOTYPE; PSYCHOLOGICAL ASPECT; REVIEW;

ANTICONVULSANTS; ANXIETY DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD BEHAVIOR DISORDERS; CHILD DEVELOPMENT DISORDERS, PERVASIVE; COMORBIDITY; DEPRESSIVE DISORDER; EPILEPSY; HUMANS; PHENOTYPE;

EID: 84866935906     PISSN: 10407308     EISSN: 15736660     Source Type: Journal    
DOI: 10.1007/s11065-012-9212-3     Document Type: Review

References (76)

1. Achenbach, T. M. (1991). Integrative guide to the 1991 CBCl/4-18, YSR, and TRF profiles. Burlington: University of Vermont, Department of Psychology.
2. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders fourth edition test revision (DSM-IV-TR). Washington. D. C.
3. Amiet, C., Gourfinkel-An, I., Bouzamondo, A., Tordjman, S., Baulac, M., Lechat, P., et al. (2008). Epilepsy in autism is associated with intellectual disability and gender: evidence form a meta-analysis. Biological Psychiatry, 64, 577-582. doi:10.1016/j.bio.psych.2008.04.030.
4. Anagnostou, E., Esposito, K., Soorya, L., Chaplin, W., Wasserman, S., & Hollander, E. (2006). Sivalproex versus placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder. Journal of Clinical Psychopharmacology, 26(4), 444-446. doi: 10.1097/01.jcp. 0000227703.72117.bc.
5. American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders Test Revision (DSM-IV-TR). Washington. D. C
6. Austin, K. J., & Caplan, R. (2007). Behavioural and psychiatric co-morbidities in paediatric epilepsy: toward an integrative model. Epilepsia, 48(9), 1639-1651. doi: 10.1111/j.1 528-1167.2007.01154.x.
7. Baird, G., Simonoff, E., Pickles, A., Chandler, S., Loucas, T., Meldrum, T., et al. (2006). Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet, 368, 210-215. doi: 10.1016/S0140-6736 (06) 69041-7.
8. Baron-Cohen, S., Wheelwright, S., Hill, J., Raste, Y., & Plumb, I. (2001). The "reading the mind in the eyes" test revised version: a study with normal adults, and adults with Asperger syndrome or high-functioning autism. Journal of Child Psychology and Psychiatry and Allied Disciplines, 42(2), 241-251. doi: 10.1111/1469-7610.00715.
9. Bellini, S. (2004). Social skill deficits and anxiety in high-functioning adolescents with autism spectrum disorders. Focus on Autism and Other Developmental Disabilities, 19, 78-86. doi:10.1177/10883576040190020201.
10. Bellini, S. (2006). The development of social anxiety in adolescents with autism spectrum disorders. Focus on Autism and Other Developmental Disabilities, 21, 138-145. doi:10.1177/10883576060210030201.
11. Belsito, K. M., Law, P. A., Kirk, K. S., Landa, R. J., & Zimmerman, A. W. (2001). Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial. Journal of Autism and Developmental Disorders, 31(2), 175-181. doi:10.1023/A:1010799115457.
12. Berg, A. T., & Plioplys, S. (2012). Epilepsy and autism: is there a special relationship? Epilepsy and Behaviour, 23(3), 193-198. doi:10.1016/j.yebeh.2012.01.015.
13. Berg, A. T., Caplan, R., & Hesdorffer, D. C. (2011). Psychiatric and neurodevelopmental disorders in childhood-onset epilepsy. Epilepsy and Behaviour, 20, 550-555. doi:10.1016/jyebeh.2010.12.038.
14. Bolton, P. F., Carcani-Rathwell, I., Hutton, J., Goode, S., Howlin, P., & Rutter, M. (2011). Epilepsy in autism: features and correlates. The British Journal of Psychiatry, 198, 289-294. doi:10.1192/bjp. bp. 109.076877.
15. Brooks-Kayal, A. (2010). Epilepsy and autism spectrum disorders: are there common developmental mechanisms? Brain and Development, 31, 731-738. doi:10.1016/j.braindev. 2010.04.010.
16. Caplan, R., Siddarth, P., Stahl, L., Lanphier, E., Vona, P., Gurbani, S., et al. (2008). Childhood absence epilepsy: behavioural, cognitive, and linguistic comorbidities. Epilepsia, 49(11), 1838-1846. doi: 10.1111/j.1528-1167.2008.01680.x.
17. Charman, T., Pickles, A., Simonoff, S., Chandler, T., Loucas, T., & Baird, G (2011). IQ in children with autism spectrum disorders: data from the Special Needs and Autism Project (SNAP). Psychological Medicine, 41, 619-627. doi: 10.1017/S0033291710000991.
18. Childs, J. A., & Blair, J. L. (1997). Valproic acid treatment of epilepsy in autistic twins. Journal of Neuroscience Nursing, 29(4), 244-248.
19. Clarke, D. F., Roberts, W., Daraksan, M., Dupuis, A., McCabe, J., Wood, H, et al. (2005). The prevelance of autistic spectrum disorder in children surveyed in a tertiary care epilepsy clinic. Epilepsia, 46(12), 1970-1977. doi: 10.1111/j. 1528-1167.2005.00343.x.
20. Costello, E. J., Mustillo, S., Erkanli, A., Keeler, G., & Angold, A. (2003). Prevalence and development of psychiatric disorders in childhood and adolescence. Archives of General Psychiatry, 60, 837-844.
21. Danielsson, S., Gillberg, C., Billstedt, E., Gillberg, C., & Olsson, I. (2005). Epilepsy in young adults with autism: a prospective population-based follow-up study of 120 individuals diagnosed in childhood. Epilepsia, 46(6), 918-923.
22. Davanzo, P. A., & King, B. H. (1996). Open trial lamotrigine in the treatment of self-injurious behaviour in an adolescent with profound mental retardation. Journal of Adolescent Psychopharmacology, 6(4), 273-279.
23. Davies, S., Heyman, I., & Goodman, R. (2003). A population survey of mental health problems in children with epilepsy. Developmental Medicine and Child Neurology, 45, 292-295. doi:10.1017/S0012162203000550.
24. Depositario-Cabacar, D. F., & Zelleke, T.-G (2010). Treatment of epilepsy in children with developmental disabilities. Developmental Disabilities Reviews, 16, 239-247. doi:10.1002/ddrr.116.
25. Desai, J., & Mitchell, W. G (2011). Does one more medication help? Effect of adding another anticonvulsant in childhood epilepsy. Journal of Child Neurology, 26(3), 329-333. doi:10.1177/0883073810380916.
26. Dritschel, B., Wisely, M., Goddard, L., Robinson, S. J., & Howlin, P. (2010). Judgements of self-understanding in adolescents with Asperger syndrome. Autism, 14, 509-518. doi:10.1177/1362361310368407.
27. Dunn, D. W., Austin, J. K., & Perkins, S. M. (2008). Prevalence of psychopathology in childhood epilepsy: categorical and dimensional measures. Developmental Medicine and Child Neurology, 51, 364-372. doi:10.111/j.1469-8749. 2008.03172.x.
28. Gaitatzis, A., Trimble, M. R., & Sander, J. W. (2004). The psychiatric comorbidity of epilepsy. Acta Neurologica Scandinavica, 110(4), 207-220. doi: 10.1111/j.1600-0404.2004.00324.x.
29. Gillberg, C. (1991). The treatment of epilepsy in autism. Journal of Autism and Developmental Disorders, 21(1), 61-77. doi:10.1007/BF02206998.
30. Giovanardi-Rossi, P., Posar, A., & Parmeggiani, A. (2000). Epilepsy in adolescents and young adults with autistic disorder. Brain Development, 22(2), 102-106. doi:10.1016/S0387-7604 (99) 00124-2.
31. Hamed, S. A. (2009). The aspects and mechanisms of cognitive alterations in epilepsy: the role of antiepileptic medications. CNS Neuroscience and Therapeutics, 15, 134-156. doi: 10.1111/j.1755-5949.2008.00062.x.
32. Happé, F., & Ronald, A. (2008). The 'fractionable autism triad': a review of evidence from behavioural, genetic, cognitive and neural research. Neuropsychology Review, 18(4), 287-304. doi: 10.1007/s1 1065-008-9076-8.
33. Hardan, A. Y., Jou, R. J., & Handen, B. L. (2004). A retrospective assessment of topiramate in children and adolescents with pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology, 14(3), 426-462. doi:10.1089/cap. 2004.14.426.
34. Hill, E. L. (2004). Evaluating the theory of executive dysfunction in autism. Developmental Review, 24, 189-233. doi:10.1016/j.tics.2003.11.003.
35. Hilty, D. M., Rodriguez, G. D., & Hales, R. E. (1998). Intravenous valporate for rapid stabilization of agitation in neuropsychiatric disorders. The Journal of Neuropsychiatry and Clinical Neurosciences, 10, 365-366.
36. Hollander, E., Dolgoff-Kaspar, R., Cartwright, C., Rawitt, R., & Novotny, S. (2001). An open trial of divalproex sodium in autism spectrum disorders. Journal of Clinical Psychiatry, 62(7), 530-534.
37. Hollander, E., Soorya, L., Wasserman, S., Esposito, K., Chaplin, W., & Anagnostou, E. (2006). Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder. International Journal of Neuropsychophamacology, 9(2), 209-213.
38. Jones, J. E., Watson, R., Sheth, R., Caplan, R., Koehn, M., Seidenberg, M., et al. (2007). Psychiatric comorbidity in children with new onset epilepsy. Developmental Medicine and Child Neurology, 49(7), 493-497. doi:10.1111/j.1469- 8749.2007.00484.x.
39. Lind, S. E. (2010). Memory and the self in autism: a review and theoretical framework. Autism, 14, 430-456. doi:10.1177/1362361309358700.
40. Mahoney, W. J., Szatmari, P., MacLean, J. E., Bryson, S. E., Bartolucci, G., Walter, S., et al. (1998). Reliability and accuracy of differentiating pervasive developmental disorder subtypes. Journal of the American Academy of Child and Adolescent Psychiatry, 37(3), 278-285. doi:10.1097/00004583-199803000- 00012.
41. Mandy, W., Charman, T., Gilmore, J., & Skuse, D. (2011). Towards specifying pervasive developmental disorder-not otherwise specified. Autism Research, 4(2), 121-131. doi:10.1002/aur.178.
42. Matson, J. L., Neal, D., Hess, J. A., Mahan, S., & Fodstad, J. C. (2010). The effect of seizure disorder on symptom presentation in atypically developing children and children with autism spectrum disorders based on the BDI-2. Developmental Neurorehabilitation, 13(5), 310-314. doi:10.3109/ 17518421003782192.
43. Matsuo, M., Maeda, T., Sasaki, K., Ishii, K., & Hamasaki, Y. (2010). Frequent association of autism spectrum disorder in patients with childhood onset epilepsy. Brain and Development, 32, 759-763. doi:10.1016/j.braindev. 2010.05.005.
44. Nass, R., & Petrucha, D. (1990). Acquired aphasia with convulsive disorder: a pervasive developmental disorder variant. Journal of Child Neurology, 5, 327-328.
45. National Institute for Health and Clinical Excellence. (2004). The epilepsies: The diagnosis and management of the epilepsies in adults and children in primary and secondary care CG20. London: National Institute for Health and Clinical Excellence.
46. Newschaffer, C. J., Croen, L. A., Daniels, J., Giarelli, E., Grether, J. K., Levy, S. E., et al. (2007). The epidemiology of autism spectrum disorders. Annual Review of Public Health, 28, 235-258.
47. Nomura, Y., Nagao, Y., Kimura, K., Hachimori, K., & Segawa, M. (2010). Epilepsy in autism: a pathophysiological consideration. Brain Development, 20(10), 799-804. doi:10.1016/j.braindev. 2010.08.001.
48. Park, S.-P. P., & Kwon, S.-H. (2008). Cognitive effects of antiepileptic drugs. Journal of Clinical Neurology, 4(3), 99-106. doi:10.3988%2Fjcn. 2008.4.3.99.
49. Pavone, P., Incorpora, G., Fiumara, A., Parano, E., Trifiletti, R. R., & Ruggieri, M. (2004). Epilepsy is not a prominent feature of primary epilepsy. Neuropediatrics, 35(4), 207-210. doi:10.1055/s-2004-821079.
50. Plioplys, A. V. (1994). Autism: electroencephalogram abnormalities and clinical improvement with valproic acid. Archives of Pediatric Adolescent Medicine, 148, 220-222.
51. Polanczyk, G., De Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007). The worldwide prevalence of ADHD: a systemic review and metaregression analysis. The American Journal of Psychiatry, 164(6), 942-948.
52. Ramsay, J. R., Brodkin, E. S., Cohen, M. R., Listerud, J., Rostain, A. L., & Ekman, E. (2005). "Better strangers": using the relationship in psychotherapy for adult patients with Asperger syndrome. Psychotherapy: Theory, Research, Practice, Training, 42, 482-493.
53. Reilly, C. J. (2011). Attention deficit hyperactivity disorder (ADHD) in childhood epilepsy. Research in Developmental Disabilities, 32, 883-893. doi:10.1016/j.ridd.2011.01.019.
54. Reilly, C., Agnew, R., & Neville, B. G. R. (2011). Depression and anxiety in childhood epilepsy: a review. Seizure, 20, 589-597. doi:10.1016/j.seizure.2011.06.004.
55. Rezaei, V., Mohammadi, M.-R., Ghanizadeh, A., Sahraian, A., Tabrizi, M., Rexaxadeh, S.-A., et al. (2010). Double-blind, placebocontrolled trial of risperidone plus topiramate in children with autistic disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 34, 1269-1272. doi:10.1016/j.pnpbp. 2010.07.005.
56. Robinson, S. J., Goddard, L., Drischel, B., Wisley, M., & Howlin, P. (2009). Executive functions in children with Autism Spectrum Disorders. Brain and Cognition, 71(3), 362-368. doi:10.1016/j.bandc.2009.06.007.
57. Ronald, A., Happé, F., Price, T. S., Baron-Cohen, S., & Plomin, R. (2006). Phenotypic and genetic overlap between autistic traits at the extremes of the general population. Journal of the American Academy of Child and Adolescent Psychiatry, 45(10), 1206-1214. doi:0.1097/01.chi.0000230165. 54117.41.
58. Rutter, M. (1970). Autistic children: infancy to adulthood. Seminars in Psychiatry, 2(4), 435-450.
59. Rutter, M. (2005). Aetiology of autism: findings and questions. Journal of Intellectual Disability Research, 49(4), 231-238. doi:10.1111/j.1365-2788. 2005.00676.
60. Rutter, M., Bailey, A., & Lord, C. (2003). Social communication questionnaire. Los Angeles: Western Psychological Services.
61. Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T., & Baird, G. (2008). Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. Journal of the American Academy of children and Adolescent Psychiatry, 47, 921-929. doi:10.1097/CHI.0b013e318179964f.
62. Smith, K. R. M., & Matson, J. L. (2010a). Psychopathology: differences among adults with intellectually disabled, comorbid autism spectrum disorders and epilepsy. Research in Developmental Disabilities, 31, 743-749. doi:10.1016/j.ridd.2010.01.016.
63. Smith, K. R. M., & Matson, J. L. (2010b). Behaviour problems: differences among intellectually disabled adults with co-morbid autism spectrum disorders and epilepsy. Research in Developmental Disabilities, 31, 1062-1069. doi:10.1016/j.ridd.2010.04.003.
64. Smith, K. R. M., & Matson, J. L. (2010c). Social skills: differences among adults with intellectual disabilities, co-morbid autism spectrum disorders and epilepsy. Research in Developmental Disabilities, 31, 1366-1372. doi:10.1016/j.ridd.2010.07.002.
65. Spence, S. J., & Schneider, M. T. (2009). The role of epilepsy and epileptiform EEGs in autism spectrum disorders. Pediatric Research, 65(6), 599-606. doi:10.1203/PDR.0b013e31819e7168.
66. Steffenburg, S., Steffenburg, U., & Gillberg, G. (2003). Autism spectrum disorders in children with active epilepsy and learning disability: comorbidity, pre-and perinatal background, and seizure characteristics. Developmental Medicine and Child Neurology, 45, 724-730. doi:10.1017/ S0012162203001361.
67. Tharp, B. R. (2004). Epileptic encephalopathies and their relationship to developmental disorders: do spikes cause autism? Developmental Disabilities Research Reviews, 10(2), 132-134. doi:10.1002/mrdd.20025.
68. Tuchman, R. (2004). AEDs and psychotropic drugs in children with autism and epilepsy. Mental Retardation and Developmental Disabilities Research Reviews, 10, 135-138. doi:10.1002/mrdd.20026.
69. Tuchman, R., Alessandri, M., & Cuccaro, M. (2010a). Autism spectrum disorders and epilepsy: moving towards a comprehensive approach to treatment. Brain and Development, 32, 719-730. doi:10.1016/j.braindev. 2010.05.007.
70. Tuchman, R., Cuccaro, M., & Alessandri, M. (2010b). Autism and epilepsy: historical perspective. Brain and Development, 32, 709-718. doi:10.1016/j.braindev. 2010.04.008.
71. Turk, J., Bax, M., Williams, C., Amin, P., Eriksson, M., & Gillberg, C. (2009). Autism spectrum disorder in children with and without epilepsy: impact on social functioning and communication. Acata Paediatrica, 98, 675-681. doi:10.1111/j.1651-2227.2008.01184.x.
72. Uvebrant, P., & Bauziené, R. (1994). Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizurerelated benefits. Neuropediatrics, 25(6), 284-289.
73. Vickerstaff, S., Heriot, S., Wong, M. G., Lopes, A., & Dossetor, D. (2007). Intellectual ability, self-perceived social competence and depressive symptomatology in children with high-functioning autistic spectrum disorders. Journal of Autism and Developmental Disorders, 37(9), 1647-1664. doi:10.1007/s10803-006-0292-x.
74. Wasserman, S., Iyengar, R., Chaplin, W. F., Watner, D., Waldoks, S. E., Anagnostou, E., et al. (2006). Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study. International Clinical Psychopharmacology, 21(6), 363-367. doi:10.1097/01.yic.0000224787. 13782.0f.
75. Wolf, P. (2005). Determinants of outcome in childhood epilepsy. Acta Neurologica Scandinavica, 112(s182), 5-8. doi:10.1111/j.1600-0404.2005.00520.x.
76. World Health Organisation. (1993). International classification of diseased and related health problems (10th ed.). Geneva, Switzerland.